INS and type 2 diabetes mellitus: In early-stage T2D, targeted interventions at these nodes—using insulin sensitizers, anti-inflammatory agents, antioxidants, or microbiome modulation—may facilitate the restoration of neurochemical equilibrium and metabolic function [146,147,148].